Table 3.
Estimated Percent Differences in Day-to-Day Impact of Vaginal Aging (DIVA) Impact Scores for Activities of Daily Living, Emotional Well-Being, and Self-Concept/Body Image Domains Associated with Participant Characteristics.
| Subscale Domain | Estimated % Difference in DIVA Scale Scores (95%CI)* | ||
|---|---|---|---|
| Activities of Daily Living Domain N=715 |
Emotional Well-Being Domain N=715 |
Self Concept/Body Image Domain N=714 |
|
| Latina/Hispanic vs. Non-Latina White | −11.2 (−29.1, 6.7) | −13.4 (−33.4, 6.7) | −40.9 (−63.1, −18.6)c |
| Black/African-American vs. Non-Latina White | 1.3 (−17.9, 20.5) | −12.3 (−33.8, 9.2) | −22.1 (−45.9, 1.8) |
| Asian/Asian-American vs. Non-Latina White | 9.9 (−9.2, 28.9) | 17.2 (−4.2, 38.5) | −11.1 (−34.8, 12.7) |
| Age (per each 5 year increase) | −0.8 (−4.9, 3.4) | −4.0 (−8.6, 0.7) | −5.4 (−10.5, −0.2)a |
| Less than weekly sexual activity | 1.9 (−15.1, 18.8) | 9.7 (−9.3, 28.7) | 37.7 (16.6, 58.8)c |
| Current spouse/sex partner | −4.3 (−22.0, 13.3) | −24.2 (−44.0, −4.5)a | 1.6 (−20.3, 23.5) |
| No college degree | 13.1 (−1.4, 27.7) | 16.3 (0.04, 32.6)a | −4.8 (−22.9, 13.3) |
| Fair/poor general self-reported health | 20.2 (2.0, 38.5)a | −02.8 (−23.2, 17.7) | 14.0 (−8.6, 36.6) |
| Body mass index (per each 1 unit increase) | 2.0 (1.0, 3.1)c | 0.4 (−0.8, 1.5) | −0.9 (−2.2, 0.4) |
| Bilateral oophorectomy | 15.1 (−14.3, 44.5) | 24.8 (−8.1, 57.8) | 27.9 (−8.7, 64.4) |
| Hospital Anxiety and Depression Scale-depression subscale (per each 3 unit increase) | 11.4 (4.4, 18.5)b | 21.8 (13.9, 29.7)c | 20.8 (12.0, 29.5)c |
| Selective serotonin reuptake inhibitor use | 3.4 (−15.4, 22.2) | 8.9 (−12.1, 30.0) | −1.0 (−24.4, 22.4) |
| Diabetes mellitus | 9.3 (−7.0, 25.5) | 5.9 (−12.3, 24.1) | −35.2 (−55.4, −15.0)c |
| Weekly urinary incontinence | 34.1 (19.8, 48.4)c | 36.8 (20.8, 52.8)c | 26.7 (8.9, 44.5)b |
| Hot flashesd | 14.3 (−1.8, 30.5) | 6.8 (−11.2, 24.9) | 7.9 (−12.1, 28.0) |
| Systemic estrogen use | 18.1 (−5.4, 41.6) | −7.6 (−34.0, 18.7) | −19.3 (−48.7, 10.2) |
| Vaginal estrogen use | 0.6 (−18.2, 19.3) | 3.7 (−17.3, 24.8) | 21.1 (−2.2, 44.4) |
*
Values greater than 0 indicate increased symptom impact associated with the predictor. Adjusted estimated % difference obtained from multivariable regression model controlling for all predictors listed in the table.
a
indicates p < .05
b
indicates p < .01
c
indicates p < .001
d
Women were considered to have hot flashes if they reported being at least “moderately” bothered by hot flashes in the past month.